Terence K. Lee
Hong Kong Island
Hong Kong, HCW, Hong Kong Special Administrative Region
Hong Kong, HCW, Hong Kong Special Administrative Region
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Advancing Cancer Biology: Highlights from the 2025 FASEB SRC on Cellular Plasticity in Cancer.
Journal: Cancer heterogeneity and plasticity
Published: November 12, 2025
AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse models.
Journal: Science translational medicine
Published: July 30, 2025
p38β-mediated BiP phosphorylation drives stemness and chemoresistance by suppressing UPR activation in hepatocellular carcinoma.
Journal: Nature communications
Published: July 30, 2025
Secreted lumican from the tumor microenvironment potentiates HCC stemness and progression.
Journal: Hepatology communications
Published: December 31, 2024
DGKH-mediated phosphatidic acid oncometabolism as a driver of self-renewal and therapy resistance in HCC.
Journal: Hepatology (Baltimore, Md.)
Published: May 13, 2024
Injection Techniques to Reduce Adverse Effects of Subcutaneous Low-Molecular-Weight Heparin Among Patients With Cardiovascular Diseases: A Scoping Review.
Journal: Journal of advanced nursing
Published: April 16, 2024
The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: March 13, 2024
CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: August 12, 2023
SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma.
Journal: Nature communications
Published: April 14, 2023
SERPINA12 promotes the tumorigenic capacity of HCC stem cells through hyperactivation of AKT/β-catenin signaling.
Journal: Hepatology (Baltimore, Md.)
Published: April 22, 2022
Last Updated: 09/26/2026